EJORVI
Live / Allowed — Fifth extension granted (statement of use) (as of 09 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Jul 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97514066
- Mark type
- Word mark
- Filed
- 21 Jul 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Makiko Coffland
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders
Owner
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
Prosecution history
- 30 Aug 2026 — PETITION TO DIRECTOR GRANTED
- 28 Aug 2026 — ASSIGNED TO PETITION STAFF
- 22 Jul 2026 — TEAS PETITION TO DIRECTOR RECEIVED
- 09 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2026 — SOU EXTENSION 5 GRANTED
- 24 Feb 2026 — SOU EXTENSION 5 FILED
- 09 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2025 — SOU EXTENSION 4 GRANTED
- 22 Aug 2025 — SOU EXTENSION 4 FILED
- 22 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2025 — SOU EXTENSION 3 GRANTED
- 27 Feb 2025 — SOU EXTENSION 3 FILED